Noremac469 vs Jin | 39–25 | 60.94% |
Noremac469 vs King | 30–21 | 58.82% |
Noremac469 vs Kazuya | 27–24 | 52.94% |
Noremac469 vs Heihachi | 28–11 | 71.79% |
Noremac469 vs Lee | 18–20 | 47.37% |
Noremac469 vs Bryan | 23–9 | 71.88% |
Noremac469 vs Hwoarang | 14–17 | 45.16% |
Noremac469 vs Xiaoyu | 15–13 | 53.57% |
Noremac469 vs Steve | 15–13 | 53.57% |
Noremac469 vs Dragunov | 16–11 | 59.26% |
Noremac469 vs Reina | 18–9 | 66.67% |
Noremac469 vs Azucena | 15–11 | 57.69% |
Noremac469 vs Lili | 14–9 | 60.87% |
Noremac469 vs Paul | 11–11 | 50.00% |
Noremac469 vs Clive | 7–13 | 35.00% |
Noremac469 vs Jun | 8–10 | 44.44% |
Noremac469 vs Asuka | 11–6 | 64.71% |
Noremac469 vs Feng | 8–9 | 47.06% |
Noremac469 vs Raven | 8–8 | 50.00% |
Noremac469 vs Yoshimitsu | 10–5 | 66.67% |
Noremac469 vs Leo | 6–9 | 40.00% |
Noremac469 vs Victor | 7–8 | 46.67% |
Noremac469 vs Devil Jin | 7–7 | 50.00% |
Noremac469 vs Alisa | 6–7 | 46.15% |
Noremac469 vs Jack-8 | 7–5 | 58.33% |
Noremac469 vs Lars | 6–6 | 50.00% |
Noremac469 vs Leroy | 5–7 | 41.67% |
Noremac469 vs Lidia | 7–4 | 63.64% |
Noremac469 vs Law | 7–3 | 70.00% |
Noremac469 vs Kuma | 4–5 | 44.44% |
Noremac469 vs Eddy | 6–2 | 75.00% |
Noremac469 vs Claudio | 4–3 | 57.14% |
Noremac469 vs Zafina | 7–0 | 100.00% |
Noremac469 vs Nina | 3–3 | 50.00% |
Noremac469 vs Shaheen | 1–3 | 25.00% |
Noremac469 vs Panda | 1–3 | 25.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.